We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.88T Turnover 6.4%
1-Year Est. Return 44.46%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+44.46%
3 Year Est. Return
+136.69%
5 Year Est. Return
+180.19%
10 Year Est. Return
+695.64%
AUM
$184B
AUM Growth
-$4.57B
Cap. Flow
-$8.49B
Cap. Flow %
-4.62%
Top 10 Hldgs %
15.06%
Holding
4,187
New
96
Increased
2,386
Reduced
984
Closed
127
Avg Time Held
2.5 years
Top 10 Avg Time Held
1.9 years
Top 20 Avg Time Held
2.2 years

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$216M
2
CHTR icon
Charter Communications
CHTR
+$192M
3
SLB icon
SLB Ltd
SLB
+$79.3M
4
IBM icon
IBM
IBM
+$70.2M
5
NWL icon
Newell Brands
NWL
+$67.5M

Sector Composition

Rank Sector Weight
1 Healthcare 14.87%
2 Technology 14.38%
3 Financials 13.98%
4 Industrials 10.32%
5 Consumer Discretionary 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GSB
3701
DELISTED
GlobalSCAPE, Inc.
GSB
$108K ﹤0.01%
29,423
– –
2014 Q1
9 quarters
STLY
3702
DELISTED
Stanley Furniture Co Inc
STLY
$108K ﹤0.01%
44,313
– –
2013 Q2
12 quarters
ANIX icon
3703
Anixa Biosciences
ANIX
$92.8M
$107K ﹤0.01%
34,351
– –
2015 Q3
3 quarters
ATEC icon
3704
Alphatec Holdings
ATEC
$1.62B
$107K ﹤0.01%
25,521
– –
2013 Q2
12 quarters
PPIH icon
3705
Perma-Pipe International
PPIH
$229M
$107K ﹤0.01%
14,425
– –
2013 Q2
12 quarters
PDS icon
3706
Precision Drilling
PDS
$1.08B
$106K ﹤0.01%
+1,000
New +$94.7K
2016 Q2
0 quarters
SMSI icon
3707
Smith Micro Software
SMSI
$13.2M
$106K ﹤0.01%
1,127
– –
2013 Q2
12 quarters
VTNR icon
3708
DELISTED
Vertex Energy, Inc
VTNR
$106K ﹤0.01%
79,776
– –
2014 Q1
9 quarters
TCON
3709
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$106K ﹤0.01%
122
– –
2015 Q2
4 quarters
SRT
3710
DELISTED
Startek Inc.
SRT
$106K ﹤0.01%
24,419
– –
2013 Q2
12 quarters
TPLM
3711
DELISTED
Triangle Petroleum Corporation
TPLM
$106K ﹤0.01%
371,147
-45,293
-11% -$17.2K
2013 Q2
12 quarters
RVP icon
3712
Retractable Technologies
RVP
$17.2M
$105K ﹤0.01%
41,762
– –
2013 Q2
12 quarters
CCLP
3713
DELISTED
CSI Compressco LP
CCLP
$105K ﹤0.01%
12,960
-3,677
-22% -$29.8K
2016 Q1
1 quarter
BFYT
3714
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$105K ﹤0.01%
26,772
– –
2013 Q2
12 quarters
WINT icon
3715
DELISTED
Windtree Therapeutics Inc
WINT
$105K ﹤0.01%
54,531
– –
2013 Q2
12 quarters
IPWR icon
3716
Ideal Power
IPWR
$49M
$104K ﹤0.01%
2,122
– –
2014 Q1
9 quarters
IMNN icon
3717
Imunon
IMNN
$5.72M
$103K ﹤0.01%
30
– –
2013 Q2
12 quarters
CNXR
3718
DELISTED
Connecture, Inc.
CNXR
$103K ﹤0.01%
45,967
-4,940
-10% -$10.3K
2015 Q1
5 quarters
AIM icon
3719
AIM ImmunoTech
AIM
$6.71M
$103K ﹤0.01%
17
– –
2013 Q2
12 quarters
TOUR icon
3720
Tuniu
TOUR
$54.3M
$102K ﹤0.01%
1,219
– –
2016 Q1
1 quarter
SEEL icon
3721
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
0
– –
2013 Q2
12 quarters
BONT
3722
DELISTED
Bon-Ton Stores Inc/The
BONT
$102K ﹤0.01%
72,615
– –
2013 Q2
12 quarters
MFG icon
3723
Mizuho Financial
MFG
$123B
$101K ﹤0.01%
35,596
+9,336
+36% +$28.1K
2013 Q4
10 quarters
PRSO icon
3724
Peraso
PRSO
$5.46M
$101K ﹤0.01%
31
– –
2013 Q2
12 quarters
AMRB
3725
DELISTED
American River Bankshares
AMRB
$101K ﹤0.01%
10,005
– –
2015 Q4
2 quarters

Similar funds

Geode Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Geode Capital Management held 4,187 positions worth $184B, down 2.4% from $188B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Geode Capital Management withdrew a net $8.49B in Q2 2016, closing 127 positions and reducing 984 holdings. Its most notable exit was Affymetrix Inc, an estimated $7.53B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

Against the trend, Geode Capital Management opened a new position in S&P Global worth $215M.

  • Geode Capital Management's largest Q2 2016 buy was S&P Global: 2,009,728 shares worth $215M.
  • Geode Capital Management added most to Charter Communications in Q2 2016, an estimated $192M increase.
  • Geode Capital Management's biggest Q2 2016 reduction was GE Aerospace, cutting an estimated $72.2M.
  • Geode Capital Management fully exited Affymetrix Inc in Q2 2016, selling an estimated $7.53B.
  • Geode Capital Management's ten largest holdings make up 15% of its $184B portfolio in Q2 2016.
  • Geode Capital Management opened 96 new positions and closed 127 in Q2 2016.
  • Geode Capital Management's portfolio value fell 2.4% quarter-over-quarter to $184B.

Based on Geode Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.